Treatment of lupus nephritis.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007116:Immunization, Passive; D007163:Immunosorbent Techniques; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000628:therapy; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D051379:Mice; D008814:Mice, Inbred NZB; D010951:Plasma Exchange; D012008:Recurrence; D013256:Steroids / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D013256:Steroids